Your browser doesn't support javascript.
loading
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
Buck, Amanda M; Deitchman, Amelia N; Takahashi, Saki; Lu, Scott; Goldberg, Sarah A; Bodansky, Aaron; Kung, Andrew; Hoh, Rebecca; Williams, Meghann C; Kerbleski, Marian; Maison, David P; Deveau, Tyler-Marie; Munter, Sadie E; Lombardo, James; Wrin, Terri; Petropoulos, Christos J; Durstenfeld, Matthew S; Hsue, Priscilla Y; Kelly, J Daniel; Greenhouse, Bryan; Martin, Jeffrey N; Deeks, Steven G; Peluso, Michael J; Henrich, Timothy J.
Affiliation
  • Buck AM; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Deitchman AN; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Takahashi S; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Lu S; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Goldberg SA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Bodansky A; Division of Pediatric Critical Care Medicine, University of California San Francisco, San Francisco, California, USA.
  • Kung A; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Williams MC; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Kerbleski M; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Maison DP; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Deveau TM; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Munter SE; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Lombardo J; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Wrin T; Monogram Biosciences, South San Francisco, California, USA.
  • Petropoulos CJ; Monogram Biosciences, South San Francisco, California, USA.
  • Durstenfeld MS; Division of Cardiology, University of California San Francisco, San Francisco, California, USA.
  • Hsue PY; Division of Cardiology, University of California San Francisco, San Francisco, California, USA.
  • Kelly JD; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Greenhouse B; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Martin JN; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Henrich TJ; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
J Med Virol ; 95(11): e29216, 2023 11.
Article in En | MEDLINE | ID: mdl-37988251

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Post-Acute COVID-19 Syndrome Limits: Humans Language: En Journal: J Med Virol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Post-Acute COVID-19 Syndrome Limits: Humans Language: En Journal: J Med Virol Year: 2023 Document type: Article Affiliation country: Country of publication: